Direct Connection doubles down on HEMI® power for the 2025 Specialty Equipment Market Association (SEMA) Show in Las Vegas. The performance parts brand is refueling its crate engine lineup with the ...

TV land lately has been filled with shows that are accidentally (or purposely) mirroring real-world politics. Prime Video’s hit series “The Boys” has lived in that space shamelessly for most of its ...

Infinix has mainly been using MediaTek chips to power its smartphones for several years. However, earlier this year, the company unveiled the Infinix Xpad GT, equipped with the older Snapdragon 888 ...

Qualcomm has introduced the Snapdragon 6s Gen 4, its latest mid-range mobile platform crafted on a 4nm process, enhancing performance, gaming, and photography. Qualcomm has introduced the Snapdragon ...

Qualcomm took the wraps off its latest midrange chipset – the Snapdragon 6s Gen 4. It brings a few upgrades over the 6s Gen 3, like improved CPU and GPU performance alongside support for FHD+ 144Hz ...

Qualcomm has officially unveiled its new Snapdragon 6s Gen 4 chipset, promising a big leap in performance for affordable Android phones. This new processor will power upcoming budget models from ...

Borderlands Borderlands 4 devs have "seen the discourse" about OP builds, but they're "looking at our first round of buffs" instead of nerfs – and fans are thrilled: "Looters are made to be broken" ...

Get ready to experience the impressive sight of an Infiniti QX riding on massive 34-inch wheels. In this video, watch as this stylish SUV cruises down the street, turning heads and making a statement.

Every generation has its quirks. Millennials and Gen Zers may only be a small number of years apart, but culturally, they often feel worlds away. From the way they communicate to the way they approach ...

The Chrysler 300C was Chrysler's flagship full-size sedan, launched in 2005. Upon its unveiling, it competed with cars like the Cadillac CTS, Mercedes E-Class, BMW 5 Series, and more. It was ...

From Roche’s $1.4 billion licensing deal to AstraZeneca’s presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe’s leading cancer conference over the ...